Drugs / cytomegalovirus IE-1-specific cytotoxic T lymphocytes
cytomegalovirus IE-1-specific cytotoxic T lymphocytes
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00769613 | Aug 2008 → Aug 2014 | cancer | Milton S. Hershey Medical Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cytomegalovirus IE-1-specific cytotoxic T lymphocytes | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00769613 ↗ |
| Action | Deplete | “may kill cells that are infected with cytomegalovirus” NCT00769613 ↗ |
| Modality | Cell therapy | “cytomegalovirus IE-1-specific cytotoxic T lymphocytes” NCT00769613 ↗ |